Risedronate is the latest of the bisphosphonates to be used for the management of resorptive bone disease. Clinical improvements, assessed by the incidence of fracture and changes in bone mineral ...

report the first-year outcomes of a 2-year, multicenter, parallel group, randomized, controlled trial to evaluate the efficacy and safety of twice-monthly versus daily oral risedronate for ...